BioSpace News Archive

Business

Enzolytics Inc. and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies

Enzolytics Inc. to leverage Samsung Biologics’ development and manufacturing expertise to advance both Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies to IND.

October 7, 2021
·
5 min read
Biotech Beach

Boundless Bio Presents Data on Extrachromosomal DNA (ecDNA) Driven Resistance to KRASG12C Inhibitors at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics 2021

Boundless Bio Presents Data on Extrachromosomal DNA (ecDNA) Driven Resistance to KRAS G12C Inhibitors at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics 2021

October 7, 2021
·
5 min read
Biotech Bay

Blade Therapeutics Announces Publication of Preclinical Evidence Supporting Neuroprotective Effects of Proprietary Calpain Inhibitor in a Rare Inherited Neurodegenerative Disease

Blade Therapeutics, Inc. today announced peer-reviewed publication of preclinical study data supporting the neuroprotective effects of inhibiting dimeric calpains in spinocerebellar ataxia type-3 (SCA3).

October 7, 2021
·
5 min read
Drug Development

AbbVie’s Upadacitinib (RINVOQ®) Met Primary and Most Ranked Secondary Endpoints in Phase 3 Study for Non-Radiographic Axial Spondyloarthritis

- In Study 2 of the Phase 3 SELECT-AXIS 2 clinical trial, upadacitinib (RINVOQ®) met the primary endpoint of ASAS40 at week 14 versus placebo (45 percent compared to 23 percent)[1]

October 7, 2021
·
17 min read
Genetown

Yield10 Bioscience to Participate in Maxim Group AgTech Virtual Conference

Yield10 Bioscience, Inc. announced today that President and CEO Oliver Peoples, Ph.D. will present at the Maxim Group Global AgTech Conference, which is being held virtually on October 14, 2021.

October 7, 2021
·
1 min read
Genetown

Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 FormulationNotice of allowance of ACER-001 formulation composition of matter patent application strengthens proprietary position in U.S. until 2036

Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief”), today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Acer’s patent application No. 17/196,416 for certain claims related to ACER-001 (sodium phenylbutyrate).

October 7, 2021
·
11 min read
Biotech Beach

BioCorRx Files Patent Application with the Russian Patent Office (Rospatent) for Naltrexone Implant

BioCorRx Inc. announced today that it has filed a patent application with the Russian Patent Office (Rospatent) for a biodegradable implant including naltrexone.

October 7, 2021
·
3 min read
Deals

Genesis Biotechnology Group Acquires BioBlocks to Grow the Preclinical Chemistry Services Portfolio of Genesis Drug Discovery & Development (GD3)

Genesis Biotechnology Group ® (GBG) and Contract Research Organization (CRO) announced today that it has acquired BioBlocks.

October 7, 2021
·
3 min read
Pharm Country

Bright Minds Biosciences Inc. to Webcast Live At VirtualInvestorConferences.com October 14th

BRIGHT MINDS BIOSCIENCES INC. today announced that Ian McDonald, President & CEO and Josh Blacher, VP of Corporation Development, will present live at VirtualInvestorConferences.com on October 14th.

October 7, 2021
·
2 min read
FDA

PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel

PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel 1 assay.

October 7, 2021
·
3 min read